Recital 5, Regulation (EU) 2022/4

In force

On 20 December 2020 the Authority communicated to the applicant, the Member States and the Commission its conclusion [EFSA Journal 2021;19(1):6393, 17 pp. doi:10.2903/j.efsa.2021.6393.] on whether the active substance Purpureocillium lilacinum strain PL11 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Authority made its conclusion available to the public.